159 related articles for article (PubMed ID: 2619974)
1. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients.
Monti JM
Br J Psychiatry Suppl; 1989 Oct; (6):61-5. PubMed ID: 2619974
[TBL] [Abstract][Full Text] [Related]
2. The effects of moclobemide on nocturnal sleep of depressed patients.
Monti JM; Alterwain P; Monti D
J Affect Disord; 1990 Nov; 20(3):201-8. PubMed ID: 2148341
[TBL] [Abstract][Full Text] [Related]
3. Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide.
Minot R; Luthringer R; Macher JP
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):181-9. PubMed ID: 8468440
[TBL] [Abstract][Full Text] [Related]
4. Moclobemide (Aurorix) in primary major depression.
Rihmer Z; Barsi J; Vad G; György S; Zalay B; Vég K; Gábor A
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):367-72. PubMed ID: 8208985
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men.
Steiger A; Benkert O; Holsboer F
Neuropsychobiology; 1994; 30(2-3):101-5. PubMed ID: 7800155
[TBL] [Abstract][Full Text] [Related]
6. Nortriptyline and EEG sleep in depressed patients.
Kupfer DJ; Spiker DG; Rossi A; Coble PA; Shaw D; Ulrich R
Biol Psychiatry; 1982 May; 17(5):535-46. PubMed ID: 7093390
[TBL] [Abstract][Full Text] [Related]
7. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
Tiller JW; Maguire KP; Davies BM
Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.
Casacchia M; Carolei A; Barba C; Frontoni M; Rossi A; Meco G; Zylberman MR
Pharmacopsychiatry; 1984 Jul; 17(4):122-5. PubMed ID: 6382361
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
Bizière K; Berger M
Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
Ucha Udabe R; Márquez CA; Traballi CA; Portes N
Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Lecrubier Y; Guelfi JD
Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
[TBL] [Abstract][Full Text] [Related]
12. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
13. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
14. Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
Laux G; Classen W; Sofic E; Becker T; Riederer P; Lesch KP; Struck M; Beckmann H
J Neural Transm Suppl; 1990; 32():189-95. PubMed ID: 2089089
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
Laux G; Beckmann H; Classen W; Becker T
J Neural Transm Suppl; 1989; 28():45-52. PubMed ID: 2677241
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes.
Versiani M; Oggero U; Alterwain P; Capponi R; Dajas F; Heinze-Martin G; Marquez CA; Poleo MA; Rivero-Almanzor LE; Rossel L
Br J Psychiatry Suppl; 1989 Oct; (6):72-7. PubMed ID: 2695129
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
[TBL] [Abstract][Full Text] [Related]
18. Clinical, endocrine and neurochemical effects of moclobemide in depressed patients.
Alevizos B; Hatzimanolis J; Markianos M; Stefanis CN
Acta Psychiatr Scand; 1993 Apr; 87(4):285-90. PubMed ID: 8488751
[TBL] [Abstract][Full Text] [Related]
19. Do reversed depressive symptoms occur together as a syndrome?
Spoov J; Suominen JY; Lahdelma RL; Katila H; Kymäläinen O; Isometsä E; Liukko H; Auvinen J
J Affect Disord; 1993 Feb; 27(2):131-4. PubMed ID: 8440808
[TBL] [Abstract][Full Text] [Related]
20. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
